What's Fair in Device Write-Offs
In recent months, the SEC has cracked down on technology companies that have attributed the bulk of their acquisition costs to IPR&D (in process research and development) write-offs so that it does not inflate future earnings. Now there are signals from the SEC that it is preparing to crack down on the share of acquisition costs, and medical product companies, particulary device firms, could be hit.
You may also be interested in...
The merger between virtual care companies Teladoc and Livongo will offer individuals a wide range of tech-enabled care during a time when telehealth continues to grow.
Regeneron's antibody cocktail for SARS-Cov-2 is largely in holding mode for now, but the company announced progress on other fronts including for Dupixent in COPD and the NGF inhibitor fasinumab.
Market Intel: Why Telehealth, Digital Therapies Will Provide Mental Health Support Beyond COVID-19 Crisis
In this second part of a two-part series focusing on mental health tech, Medtech Insight highlights behavioral digital health companies that have attracted investors’ attention. Part one focused on transcranial magnetic stimulation.